Ab dem 31. Januar stellt buchhandel.de die Verkaufsfunktion ein!

Bitte sichern Sie alle notwendigen Daten, wie etwa Rechnungen oder Ihre Wunschliste in Ihrem Kundenprofil.
Weitere Informationen finden Sie hier: https://www.buchhandel.de/info/hilfe.
Suche ›

Acute Leukemias II

Prognostic Factors and Treatment Strategies

Springer Berlin,
139,09 € Lieferbar in 2-3 Tagen


Acute leukemia a quite homogenous disease failed to break through the sound barriere of when untreated reveals a substantial hetero unsatisfactory cure rates even in special sub geneity in its response to therapy. While cure groups. While new protocols including more is achieved in a certain proportion of pa effective supportive care show some increase tients other cases prove to be highly resis in the initial response rates and certain im tant. The curability is superior in acute provements in the long-term results, no ben lymphoblastic (ALL) than in acute myeloid eficial effect on the relapse rate during the (AML) leukemia and - within both type- first 1 Y2 years emerged from any of these higher in children as compared to adults. regimens. Thus, high chances for cure are The two age groups and cell types can be presently restricted to children with ALL further subdivided into prognostic groups and to lesser proportions children with by special diagnostic features. Thus, in AML and adults with ALL and AML.


Titel: Acute Leukemias II
Autoren/Herausgeber: Thomas Büchner, Günther Schellong, Wolfgang HIddemann, Jörg Ritter (Hrsg.)
Aus der Reihe: Haematology and Blood Transfusion /Hämatologie und Bluttransfusion

ISBN/EAN: 9783540509844

Seitenzahl: 776
Format: 24,2 x 17 cm
Produktform: Taschenbuch/Softcover
Gewicht: 1,385 g
Sprache: Englisch

buchhandel.de - Newsletter
Möchten Sie sich für den Newsletter anmelden?

Bitte geben Sie eine gültige E-Mail-Adresse ein.
Lieber nicht